PLUR - יחס חוב להיוון בספרים pluri-biotech.com

Premium pricing for placental therapy is driving stock growth, as evidenced by the financial leverage ratio based on book capitalization. However, Middle Eastern conflicts are undermining stability, and the environmental profile is constrained by bio-waste disposal. The current value of 0.00 represents the debt load indicator, demonstrating the balance between the financial independence of Pluri Inc. (PLUR) and the pace of its business expansion.

This ratio determines the proportion of financial liabilities to equity, measuring the company's actual debt load. An increase in this value signals an overheated financing structure and heightened default risks. By analyzing the current relationship between debt and balance sheet capital, an investor assesses the sustainability of business scaling. For Pluri Inc. (PLUR), this is critical when maintaining energy-dependent bioreactors in Israel. Monitoring this metric confirms the company's ability to support costly cell therapy infrastructure.